Skip to main content
. 2018 Aug 22;4(3):00043-2018. doi: 10.1183/23120541.00043-2018

TABLE 1.

Baseline characteristics of patients with chronic hypersensitivity pneumonitis (cHP) and healthy subjects

cHP Healthy subjects
Subjects n 28 18
Females 16 (57.1) 10 (55.6)
Age years 56±11.5 54±12.8
BMI kg·m−2 27.2 (25.4–30.4) 26.6 (23–28)
Baseline dyspnoea index mMRC 1 (1–2)
Smokers 8 (29)
Oxygen saturation at rest % 94±2
Symptoms at diagnosis
 Dyspnoea 24 (86)
 Cough 23 (82)
 Wheezing 20 (71)
 Weight loss 11 (38)
 Duration of symptoms months 24 (12–45)
Exposure
 Mould 21 (75)
 Birds 18 (64)
 Feather pillow 6 (21)
 Others 3 (11)
 No recognised exposure 0 (0)
 Actual exposure/previous exposure n 4/24
Pulmonary function tests
 FVC L 2.03±0.65 3.33±0.85*
 FVC % pred 57±17 89±10*
 FEV1 L 1.75±0.52 2.74±0.62*
 FEV1 % pred 61±16 90 ±10*
 FEV1/FVC 0.87±0.05 0.82±0.04*
 FEF25–75% 98±31
 TLC L 3.37±0.90
 TLC % pred 64 (53–72)
 RV L 1.18 (1.06–1.47)
 RV % pred 77 (60–88)
 RV/TLC 0.39±0.07
DLCO % pred 42 (31–63)
HRCT findings
 Centrilobular nodules 3 (11)
 Ground-glass opacities 26 (96)
 Mosaic pattern 15 (54)
 Honeycombing 4 (14)
 Findings suggestive of fibrosis 25 (89)
 Emphysema 0 (0)
 Bronchoalveolar lavage 21 (75)
 Lymphocyte count 23 (10–38)
 CD4/CD8 ratio 0.57 (0.37–1.29)
 Lung biopsy 21 (78)
 Transbronchial 16 (59)
 Surgical 5 (19)

Data are presented as n (%), mean±sd if normally distributed or median (25th–75th percentile), unless otherwise stated. BMI: body mass index; mMRC: modified Medical Research Council; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; FEF25–75%: forced expiratory flow at 25–75% of FVC; TLC: total lung capacity; RV: residual volume; DLCO: diffusing capacity of the lung for carbon monoxide; HRCT: high-resolution computed tomography. *: p<0.05.